After years of research and development, we have a balanced and diversified product pipeline with a strategic focus on dermatology and major cancers.
Note: 1.In addition, IND for basal-cell carcinoma indication has been cleared by FDA in the U.S.
Focus Us
Copyright: 真人直营投注网站 retains all copyrights. 京ICP证000000号 Powered by 300.cn SEO Business License
Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn
Find Us
Complaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor.com.cn